Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation.
about
Pituitary pathology in Carney complex patientsMouse Models Recapitulating Human Adrenocortical Tumors: What Is Lacking?Molecular genetics of adrenocortical tumor formation and potential pharmacologic targetsCarney complex: an updateAlterations of Phosphodiesterases in Adrenocortical TumorsOsteochondromyxoma: Review of a rare carney complex criterionMEN1, MEN4, and Carney Complex: Pathology and Molecular GeneticsHuman tumors associated with Carney complex and germline PRKAR1A mutations: a protein kinase A disease!A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasiaPancreatic ductal and acinar cell neoplasms in Carney complex: a possible new associationSpotty skin pigmentation and multiple blue naevi as cutaneous markers for spinal melanotic schwannoma.Genetic predisposition to peripheral nerve neoplasia: diagnostic criteria and pathogenesis of neurofibromatoses, Carney complex, and related syndromesThe complex of myxomas, spotty skin pigmentation and endocrine overactivity (Carney complex): imaging findings with clinical and pathological correlationRecurrent right ventricular cardiac myxoma in a patient with Carney complex: a case report.[Absence of PRKAR1A loss of heterozygosity in laser-captured microdissected pigmented nodular adrenocortical tissue from a patient with Carney complex caused by the novel nonsense mutation p.Y21X].Cutaneous signs are important in the diagnosis of the rare neoplasia syndrome Carney complexACTH-independent Cushing's syndrome with bilateral micronodular adrenal hyperplasia and ectopic adrenocortical adenoma.Association of the M1V PRKAR1A mutation with primary pigmented nodular adrenocortical disease in two large families.Interaction of the regulatory subunit of the cAMP-dependent protein kinase with PATZ1 (ZNF278).Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (ARMC5) gene: a clinical and genetic investigation.Familial micronodular adrenocortical disease, Cushing syndrome, and mutations of the gene encoding phosphodiesterase 11A4 (PDE11A).A knowledge-based framework for the discovery of cancer-predisposing variants using large-scale sequencing breast cancer dataMouse Prkar1a haploinsufficiency leads to an increase in tumors in the Trp53+/- or Rb1+/- backgrounds and chemically induced skin papillomas by dysregulation of the cell cycle and Wnt signalingRegulation of steroidogenesis in a primary pigmented nodular adrenocortical disease-associated adenoma leading to virilization and subclinical Cushing's syndrome.Large-cell calcifying Sertoli cell tumors of the testes in pediatrics.PRKAR1A and the evolution of pituitary tumors.Mutations and polymorphisms in the gene encoding regulatory subunit type 1-alpha of protein kinase A (PRKAR1A): an update.Solid tumors associated with multiple endocrine neoplasias.Ectopic thymus presenting as a thyroid nodule in a patient with the Carney complexCarney complex and other conditions associated with micronodular adrenal hyperplasias.Protein kinase A regulates caspase-1 via Ets-1 in bone stromal cell-derived lesions: a link between cyclic AMP and pro-inflammatory pathways in osteoblast progenitors.Post-operative growth is different in various forms of pediatric Cushing's syndromeCarney complex (CNC).Carney-Complex: multiple resections of recurrent cardiac myxomaUse of aromatase inhibitors in large cell calcifying sertoli cell tumors: effects on gynecomastia, growth velocity, and bone ageHow does cAMP/protein kinase A signaling lead to tumors in the adrenal cortex and other tissues?Cushing's syndrome secondary to isolated micronodular adrenocortical disease (iMAD) associated with rapid onset weight gain and negative abdominal MRI findings in a 3 year old male.Targeted deletion of Prkar1a reveals a role for protein kinase A in mesenchymal-to-epithelial transition.Cushing syndrome caused by adrenocortical tumors and hyperplasias (corticotropin- independent Cushing syndrome)A novel PRKAR1A mutation associated with hepatocellular carcinoma in a young patient and a variable Carney complex phenotype in affected subjects in older generations.
P2860
Q24647038-4D15927C-3775-4C3E-A5BE-6B873DB0ECD5Q26740687-85BE4A77-43FD-4C1C-A7BE-0C7ABD6EDD8BQ26849995-02EA3605-918F-4078-9F52-08D0BE64E544Q27026529-A05D2627-746D-447C-B39B-CC5574DFB8AAQ28066278-0D3D46C6-6650-4261-86F7-27C03BEDB4ACQ28073245-1B7CCBE1-37B7-4AAF-AAF4-360DF89DC7CDQ28088746-066DEB3F-2708-4118-BFD3-4A2A185CFB3CQ28182362-E474370C-5085-4680-B935-31A616D6F7CBQ28245373-151987E6-821A-44F8-A1EF-6108BD46E27DQ28247409-F1152181-867A-46DE-9C7A-6F41998D954EQ30389199-D8EB506D-B5F9-467D-B5F7-95687BF2E542Q30454537-AEB50253-41A8-4AB6-90A5-A6A568F7B864Q30457896-B905FC3E-4335-4285-9BAF-DCF5C648DE85Q30579140-97EFB354-2445-47CF-827A-4DD8AD548D0DQ33402933-BF4DC072-9917-41B2-8541-9E04237F6D74Q33409532-721B02AB-0172-447A-931E-B8C197C20448Q33586715-2439A915-A408-4EAE-853B-599D18BE9B20Q33586753-0C736EB3-43E6-4912-A18C-AD73DDCCDCCFQ33615712-1674407E-FEA9-4680-8E46-BBAF54CD48BDQ33682397-994D4A05-12F5-4DA3-919D-E455B05EA246Q33701874-2982FD08-9F80-4E25-BCFE-82FD7E4E8785Q33750026-A9C23503-CC13-49AC-B92E-D3C76CCF1159Q33755811-A58746F1-91B1-42B1-8F60-13CE4B43ACD6Q33909917-68DA660B-BC2A-4872-96E7-05F00188E471Q34045351-FEADACD8-E757-42A1-BD48-E8CAEDDBD742Q34070989-E22259C3-CE8B-4684-A0FB-ED48F9930AE3Q34113281-0E15D426-109A-46E3-88BC-973C748B5911Q34213017-E6F3DBE6-116B-4D4C-B54C-FD8632CA43FDQ34234161-D5224085-6274-4995-AC47-59F11EF3C3D7Q34398710-1D872721-1710-4E26-8331-5318D42C273CQ34399430-EDB34196-149F-442D-A8C1-35039198DDB1Q34403758-E7FB523B-5708-4B87-8765-E941B67CA0A9Q34568138-CA46E830-AF93-4754-9CA7-3E9AF97700E6Q34573707-A2FC55C6-69D7-4EF1-A65C-CBE8C05BC86EQ34628355-14C480BD-8202-4D85-9C0F-22037403C36EQ34629130-88CDAEC5-60A0-42A9-A78F-864AAC288FF8Q34982420-34CD894D-FBF6-4B60-A3A3-B0CA2930FC84Q35086077-E687FFC7-20BA-49BD-B933-B58189C38645Q35095366-F3D7F133-0521-4690-A54A-A7379990CB14Q35104094-86B74FAF-D4BC-48CE-80FD-9561B78C0487
P2860
Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Clinical and molecular feature ...... ations for patient evaluation.
@ast
Clinical and molecular feature ...... ations for patient evaluation.
@en
Clinical and molecular feature ...... ations for patient evaluation.
@nl
type
label
Clinical and molecular feature ...... ations for patient evaluation.
@ast
Clinical and molecular feature ...... ations for patient evaluation.
@en
Clinical and molecular feature ...... ations for patient evaluation.
@nl
prefLabel
Clinical and molecular feature ...... ations for patient evaluation.
@ast
Clinical and molecular feature ...... ations for patient evaluation.
@en
Clinical and molecular feature ...... ations for patient evaluation.
@nl
P2093
P356
P1476
Clinical and molecular feature ...... ations for patient evaluation.
@en
P2093
Kirschner LS
Stratakis CA
P304
P356
10.1210/JCEM.86.9.7903
P407
P577
2001-09-01T00:00:00Z